Disruption of LEDGF/p75-directed integration derepresses antisense transcription of the HIV-1 genome
Philip R. Tedbury,Darius Mahboubi,Maritza Puray-Chavez,Raven Shah,Obiaara B. Ukah,Claudia C. Wahoski,Hind J. Fadel,Eric M. Poeschla,Xinlin Gao,William M. McFadden,Maria Gaitanidou,Nikolaos Kesesidis,Karen A. Kirby,Thomas H. Vanderford,Mamuka Kvaratskhelia,Vasudevan Achuthan,Ryan T. Behrens,Alan N. Engelman,Stefan G. Sarafianos
DOI: https://doi.org/10.1101/2024.12.06.627169
2024-12-06
Abstract:Disruption of HIV-1 Integrase (IN) interactions with the host-factor Lens Epithelium-Derived Growth Factor (LEDGF)/p75 leads to decreased, random integration, increased latent infection, and described here, accumulation of HIV-1 antisense RNA (asRNA). asRNA increase was observed following interruptions of IN-LEDGF/p75 interactions either through pharmacologic perturbations of IN-LEDGF/p75 by treatment with allosteric HIV-1 integrase inhibitors (ALLINIs) or in cell lines with LEDGF genetic knockout. Additionally, by impairing Tat-dependent HIV transcription, asRNA abundance markedly increases. Illumina sequencing characterization of asRNA transcripts in primary T cells infected in the presence of ALLINIs showed that most initiate from within the HIV-1. Overall, loss of IN-LEDGF/p75 interactions increase asRNA abundance. Understanding the relationship between ALLINIs, integration sites, asRNA, and latency could aid in future therapeutic strategies.
Microbiology